 | • レポートコード：D0GIR-00514 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポイントオブケア感染症診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。ポイントオブケア感染症診断の種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB・薬剤耐性TB POC）、用途別市場規模（病院、クリニック、家庭、介護福祉施設、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Sekisui Diagnostics、Chembio Diagnostic Systems、Abbott、Trinity Biotech、Calypte Biomedical、Quidel、MedMira、Meridian Bioscience、OraSure Technologies ・地域別グローバル市場分析 2015年-2020年 ・ポイントオブケア感染症診断の北米市場（アメリカ、カナダ、メキシコ） ・ポイントオブケア感染症診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポイントオブケア感染症診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポイントオブケア感染症診断の南米市場（ブラジル、アルゼンチン） ・ポイントオブケア感染症診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TB・薬剤耐性TB POC ・用途別分析：病院、クリニック、家庭、介護福祉施設、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Point-of-care Infectious Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Point-of-care Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Point-of-care Infectious Disease Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Point-of-care Infectious Disease Diagnostics market has been segmented into:
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
By Application, Point-of-care Infectious Disease Diagnostics has been segmented into:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Point-of-care Infectious Disease Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Point-of-care Infectious Disease Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point-of-care Infectious Disease Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Point-of-care Infectious Disease Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Point-of-care Infectious Disease Diagnostics Market Share Analysis
Point-of-care Infectious Disease Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Point-of-care Infectious Disease Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point-of-care Infectious Disease Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Point-of-care Infectious Disease Diagnostics are:
Thermo Fisher Scientific
Sekisui Diagnostics
Chembio Diagnostic Systems
Abbott
Trinity Biotech
Calypte Biomedical
Quidel
MedMira
Meridian Bioscience
OraSure Technologies
Table of Contents
1 Point-of-care Infectious Disease Diagnostics Market Overview
1.1 Product Overview and Scope of Point-of-care Infectious Disease Diagnostics
1.2 Classification of Point-of-care Infectious Disease Diagnostics by Type
1.2.1 Global Point-of-care Infectious Disease Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type in 2019
1.2.3 HIV POC
1.2.4 Clostridium Difficile POC
1.2.5 HBV POC
1.2.6 Respiratory Syncytial Virus POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 HCV POC
1.2.10 MRSA POC
1.2.11 TB and Drug-Resistant TB POC
1.3 Global Point-of-care Infectious Disease Diagnostics Market by Application
1.3.1 Overview: Global Point-of-care Infectious Disease Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point-of-care Infectious Disease Diagnostics Market by Regions
1.4.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Point-of-care Infectious Disease Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Point-of-care Infectious Disease Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Point-of-care Infectious Disease Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-care Infectious Disease Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Point-of-care Infectious Disease Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-care Infectious Disease Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sekisui Diagnostics
2.2.1 Sekisui Diagnostics Details
2.2.2 Sekisui Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sekisui Diagnostics SWOT Analysis
2.2.4 Sekisui Diagnostics Product and Services
2.2.5 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chembio Diagnostic Systems
2.3.1 Chembio Diagnostic Systems Details
2.3.2 Chembio Diagnostic Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Chembio Diagnostic Systems SWOT Analysis
2.3.4 Chembio Diagnostic Systems Product and Services
2.3.5 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Trinity Biotech
2.5.1 Trinity Biotech Details
2.5.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Trinity Biotech SWOT Analysis
2.5.4 Trinity Biotech Product and Services
2.5.5 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Calypte Biomedical
2.6.1 Calypte Biomedical Details
2.6.2 Calypte Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Calypte Biomedical SWOT Analysis
2.6.4 Calypte Biomedical Product and Services
2.6.5 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quidel
2.7.1 Quidel Details
2.7.2 Quidel Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quidel SWOT Analysis
2.7.4 Quidel Product and Services
2.7.5 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 MedMira
2.8.1 MedMira Details
2.8.2 MedMira Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MedMira SWOT Analysis
2.8.4 MedMira Product and Services
2.8.5 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Meridian Bioscience
2.9.1 Meridian Bioscience Details
2.9.2 Meridian Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Meridian Bioscience SWOT Analysis
2.9.4 Meridian Bioscience Product and Services
2.9.5 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 OraSure Technologies
2.10.1 OraSure Technologies Details
2.10.2 OraSure Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 OraSure Technologies SWOT Analysis
2.10.4 OraSure Technologies Product and Services
2.10.5 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Point-of-care Infectious Disease Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Point-of-care Infectious Disease Diagnostics Players Market Share
3.2.2 Top 10 Point-of-care Infectious Disease Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Point-of-care Infectious Disease Diagnostics Revenue and Market Share by Regions
4.2 North America Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Point-of-care Infectious Disease Diagnostics Revenue by Countries
5.1 North America Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
5.2 USA Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Point-of-care Infectious Disease Diagnostics Revenue by Countries
6.1 Europe Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Countries
7.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
7.2 China Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Point-of-care Infectious Disease Diagnostics Revenue by Countries
8.1 South America Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Point-of-care Infectious Disease Diagnostics by Countries
9.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Point-of-care Infectious Disease Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Point-of-care Infectious Disease Diagnostics Market Forecast by Type (2019-2024)
10.3 HIV POC Revenue Growth Rate (2015-2025)
10.4 Clostridium Difficile POC Revenue Growth Rate (2015-2025)
10.5 HBV POC Revenue Growth Rate (2015-2025)
10.6 Respiratory Syncytial Virus POC Revenue Growth Rate (2015-2025)
10.7 HPV POC Revenue Growth Rate (2015-2025)
10.8 Influenza/Flu POC Revenue Growth Rate (2015-2025)
10.9 HCV POC Revenue Growth Rate (2015-2025)
10.10 MRSA POC Revenue Growth Rate (2015-2025)
10.11 TB and Drug-Resistant TB POC Revenue Growth Rate (2015-2025)
11 Global Point-of-care Infectious Disease Diagnostics Market Segment by Application
11.1 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Point-of-care Infectious Disease Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Home Revenue Growth (2015-2020)
11.6 Assisted Living Healthcare Facilities Revenue Growth (2015-2020)
11.7 Laboratories Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast (2021-2025)
12.1 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast (2021-2025)
12.2 Global Point-of-care Infectious Disease Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Point-of-care Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Point-of-care Infectious Disease Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Major Business
Table 7. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 10. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sekisui Diagnostics Corporate Information, Location and Competitors
Table 12. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Major Business
Table 13. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Sekisui Diagnostics SWOT Analysis
Table 15. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 16. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Chembio Diagnostic Systems Corporate Information, Location and Competitors
Table 18. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Major Business
Table 19. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Chembio Diagnostic Systems SWOT Analysis
Table 21. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 22. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott Point-of-care Infectious Disease Diagnostics Major Business
Table 25. Abbott Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 28. Abbott Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Trinity Biotech Corporate Information, Location and Competitors
Table 30. Trinity Biotech Point-of-care Infectious Disease Diagnostics Major Business
Table 31. Trinity Biotech Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Trinity Biotech SWOT Analysis
Table 33. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 34. Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Calypte Biomedical Corporate Information, Location and Competitors
Table 36. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Major Business
Table 37. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Calypte Biomedical SWOT Analysis
Table 39. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 40. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Quidel Corporate Information, Location and Competitors
Table 42. Quidel Point-of-care Infectious Disease Diagnostics Major Business
Table 43. Quidel Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Quidel SWOT Analysis
Table 45. Quidel Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 46. Quidel Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. MedMira Corporate Information, Location and Competitors
Table 48. MedMira Point-of-care Infectious Disease Diagnostics Major Business
Table 49. MedMira Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. MedMira SWOT Analysis
Table 51. MedMira Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 52. MedMira Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Meridian Bioscience Corporate Information, Location and Competitors
Table 54. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Major Business
Table 55. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Meridian Bioscience SWOT Analysis
Table 57. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 58. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. OraSure Technologies Corporate Information, Location and Competitors
Table 60. OraSure Technologies Point-of-care Infectious Disease Diagnostics Major Business
Table 61. OraSure Technologies Point-of-care Infectious Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. OraSure Technologies SWOT Analysis
Table 63. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product and Solutions
Table 64. OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players (2015-2020)
Table 67. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Table 69. North America Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
Table 70. North America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Point-of-care Infectious Disease Diagnostics Revenue by Countries (2015-2020)
Table 74. South America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 77. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Type (2015-2020)
Table 79. Global Point-of-care Infectious Disease Diagnostics Revenue Forecast by Type (2021-2025)
Table 80. Global Point-of-care Infectious Disease Diagnostics Revenue by Application (2015-2020)
Table 81. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2015-2020)
Table 82. Global Point-of-care Infectious Disease Diagnostics Revenue Forecast by Application (2021-2025)
Table 83. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Point-of-care Infectious Disease Diagnostics Picture
Figure 2. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type in 2019
Figure 3. HIV POC Picture
Figure 4. Clostridium Difficile POC Picture
Figure 5. HBV POC Picture
Figure 6. Respiratory Syncytial Virus POC Picture
Figure 7. HPV POC Picture
Figure 8. Influenza/Flu POC Picture
Figure 9. HCV POC Picture
Figure 10. MRSA POC Picture
Figure 11. TB and Drug-Resistant TB POC Picture
Figure 12. Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application in 2019
Figure 13. Hospitals Picture
Figure 14. Clinics Picture
Figure 15. Home Picture
Figure 16. Assisted Living Healthcare Facilities Picture
Figure 17. Laboratories Picture
Figure 18. Others Picture
Figure 19. Global Point-of-care Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. North America Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Europe Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. South America Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 26. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Players in 2019
Figure 27. Global Top 5 Players Point-of-care Infectious Disease Diagnostics Revenue Market Share in 2019
Figure 28. Global Top 10 Players Point-of-care Infectious Disease Diagnostics Revenue Market Share in 2019
Figure 29. Key Players Market Share Trend
Figure 30. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 32. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Regions in 2018
Figure 33. North America Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. South America Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. North America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 39. North America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 40. USA Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Canada Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Mexico Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Europe Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 44. Europe Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 45. Germany Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. UK Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. France Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Russia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Italy Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 51. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 52. China Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Japan Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Korea Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. India Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Southeast Asia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 58. South America Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 59. Brazil Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Argentina Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 61. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 62. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 63. Saudi Arabia Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 64. UAE Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 65. Egypt Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 66. South Africa Point-of-care Infectious Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 67. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Type (2015-2020)
Figure 68. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Type in 2019
Figure 69. Global Point-of-care Infectious Disease Diagnostics Market Share Forecast by Type (2021-2025)
Figure 70. Global HIV POC Revenue Growth Rate (2015-2020)
Figure 71. Global Clostridium Difficile POC Revenue Growth Rate (2015-2020)
Figure 72. Global HBV POC Revenue Growth Rate (2015-2020)
Figure 73. Global Respiratory Syncytial Virus POC Revenue Growth Rate (2015-2020)
Figure 74. Global HPV POC Revenue Growth Rate (2015-2020)
Figure 75. Global Influenza/Flu POC Revenue Growth Rate (2015-2020)
Figure 76. Global HCV POC Revenue Growth Rate (2015-2020)
Figure 77. Global MRSA POC Revenue Growth Rate (2015-2020)
Figure 78. Global TB and Drug-Resistant TB POC Revenue Growth Rate (2015-2020)
Figure 79. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application (2015-2020)
Figure 80. Global Point-of-care Infectious Disease Diagnostics Revenue Share by Application in 2019
Figure 81. Global Point-of-care Infectious Disease Diagnostics Market Share Forecast by Application (2021-2025)
Figure 82. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 83. Global Clinics Revenue Growth Rate (2015-2020)
Figure 84. Global Home Revenue Growth Rate (2015-2020)
Figure 85. Global Assisted Living Healthcare Facilities Revenue Growth Rate (2015-2020)
Figure 86. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 87. Global Others Revenue Growth Rate (2015-2020)
Figure 88. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 89. Global Point-of-care Infectious Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 90. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 91. North America Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 92. Europe Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 93. Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 94. South America Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 95. Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 96. Sales Channel: Direct Channel vs Indirect Channel
感染症検査における分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…- 感染症迅速診断検査キットの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…
- ポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Polymerase Chain Reaction(PCR)for Point-of-Care(POC)Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mi…
- 感染症迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 感染症診断検査キットの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Infectious Disease Diagnostic Testing Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…